Hypofractionated radiotherapy combined with targeted therapy or immunotherapy: Dutch survey on current practice, knowledge and challenges

INTRODUCTION: With the introduction of tyrosine kinase inhibitors and systemic antibodies, including immune checkpoint inhibitors, the survival of advanced-stage cancer patients has improved for many tumor types. These patients are increasingly referred for radiotherapy, but it is unclear whether ra...

Descripción completa

Detalles Bibliográficos
Autores principales: van Aken, Evert S.M., van der Linden, Yvette M., van Thienen, Johannes V., de Langen, Adrianus J., Marijnen, Corrie A.M., de Jong, Monique C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885401/
https://www.ncbi.nlm.nih.gov/pubmed/35243019
http://dx.doi.org/10.1016/j.ctro.2022.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885401/
https://www.ncbi.nlm.nih.gov/pubmed/35243019
http://dx.doi.org/10.1016/j.ctro.2022.01.002

Ejemplares similares